What is the main purpose of this 8-K filing?

The primary purpose of this 8-K filing is to announce Gilead Sciences' financial results for the quarter ended June 30, 2023, by furnishing the accompanying press release as an exhibit.

Where can I find the detailed financial results for Q2 2023?

The detailed financial results, including both GAAP and non-GAAP figures, are located in the press release filed as Exhibit 99.1 to this 8-K report.

What is the difference between GAAP and non-GAAP measures mentioned in the report?

GAAP (Generally Accepted Accounting Principles) are standard accounting rules. Non-GAAP measures are alternative performance metrics that Gilead management believes provide useful insights into operations but are not prepared under comprehensive accounting rules and may differ from how other companies calculate them. A reconciliation is provided to help understand the differences.

Are the financial results presented in this 8-K considered 'filed' for regulatory purposes?

No, the information contained in Item 2.02 and Item 9.01 of this Form 8-K, including the press release, is furnished and not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor is it incorporated by reference into other filings.

GILD 8-K: Earnings & Results

Summary

Gilead Sciences, Inc. (GILD) announced its financial results for the quarter ended June 30, 2023, via a press release filed on August 3, 2023. The report primarily serves to furnish this press release, which contains detailed financial performance information, including both GAAP and non-GAAP measures. Investors should refer to the press release (Exhibit 99.1) for a comprehensive understanding of the company's operational performance and financial condition during the second quarter of 2023. The company utilizes non-GAAP financial measures alongside GAAP results to provide a more insightful view of its operations, budgeting, and financial planning. While these non-GAAP metrics are considered useful by management, they are not prepared under comprehensive accounting rules and should be used as supplementary information to the official GAAP financial statements. A reconciliation of GAAP to non-GAAP figures is available within the press release itself, allowing investors to compare these different reporting bases.

Key Highlights

1Gilead Sciences released its Q2 2023 financial results on August 3, 2023.
2The filing includes a press release (Exhibit 99.1) detailing the company's financial performance for the quarter ended June 30, 2023.
3Both GAAP and non-GAAP financial measures are presented in the press release.
4Management believes non-GAAP measures offer valuable insights for investors and are used internally for operational planning.
5A reconciliation between GAAP and non-GAAP financial information is provided in the press release.
6The information furnished in this 8-K is not deemed 'filed' for purposes of Section 18 of the Exchange Act.

GILEAD SCIENCES, INC. 8-K Report, Financial Results (Aug 3, 2023)

Summary

Key Highlights

Frequently Asked Questions